
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | ||
---|---|---|---|---|---|---|
Plasmid | 105557 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $75 | Add to Cart | |
AAV1 | 105557-AAV1 | Virus (100 µL at titer ≥ 1×10¹³ vg/mL)and Plasmid.More Information | Add to Cart | |||
AAV9 | 105557-AAV9 | Virus (100 µL at titer ≥ 1×10¹³ vg/mL)and Plasmid.More Information | Add to Cart |
This material is available to academics and nonprofits only.
Backbone
- Vector backbonepAAV(Search Vector Database)
- Vector typeMammalian Expression, AAV
Growth in Bacteria
- Bacterial Resistance(s)Ampicillin
- Growth Temperature37°C
- Growth Strain(s)NEB Stable
- Copy numberUnknown
Gene/Insert
- Gene/Insert namemCerulean
- PromoterCB7
Cloning Information
- Cloning methodUnknown
Resource Information
- Supplemental Documents
- pENN.AAV.CB7.CI.mCerulean.WPRE.RBG (p3248).gb
- Terms and Licenses
- UBMTA
- Vanderbilt-Cerulean
- Industry Terms
- Not Available to Industry
Depositor Comments
Penn Vector Core number p3248
Information for AAV1 (Catalog # 105557-AAV1)(Back to top)
Purpose
Ready-to-use AAV1 particles produced from pENN.AAV.CB7.CI.mCerulean.WPRE.RBG (#105557). In addition to the viral particles, you will also receive purified pENN.AAV.CB7.CI.mCerulean.WPRE.RBG plasmid DNA.
CB7-driven mCerulean expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 1×10¹³ vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV1 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV1
- PurificationIodixanol gradient ultracentrifugation
- Reporter GenemCerulean
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Information for AAV9 (Catalog # 105557-AAV9)(Back to top)
Purpose
Ready-to-use AAV9 particles produced from pENN.AAV.CB7.CI.mCerulean.WPRE.RBG (#105557). In addition to the viral particles, you will also receive purified pENN.AAV.CB7.CI.mCerulean.WPRE.RBG plasmid DNA.
CB7-driven mCerulean expression. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 1×10¹³ vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV9 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV9
- PurificationIodixanol gradient ultracentrifugation
- Reporter GenemCerulean
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
SAMPOSCPMELAPSEDSAMPLETOTALELAPSED
TIME(MIN)TIME(MIN)
1**-1827543.90.5250.892
765315.21.5251.892
729279.52.5002.867
这是使用同一个底物,但所测得值,不知道为什麽CPM值一直往下滑?
有几个问题想问问大家:
1.我看到相当多文献中,结束反应用的是抽滤,由于条件的限制,我们这里没有该装置,所以就取了少数文献中的方法,用12000G离心10min结束反应,然后沉淀TRIS-HCL洗涤3次。测量时在沉淀所在的EP管中加入闪烁液(该闪烁液的配方适用于样品含水量较少的情况),每管1ML。请问大家,这样结束反应行吗?沉淀是否应该烘干?
2.我用的液闪仪计数不是很稳定,如果进行校正,尤其是读数比较小的时候(如只有数百),以减少误差?
3.加入闪烁液后,是否应该避光放置一段时间后再测量?
谢谢!
碳14试剂检测方法
(1) 静坐25分钟后,受试者直接向集气瓶内呼气,患者呼气后集气瓶中的液体由粉红色变成无色为止,或者患者持续呼气时间已经达到3分钟后即可停止呼气。
(2) 向集气瓶中加入4.5ml稀释闪烁液后,加盖旋紧,置于液闪仪中进行检测。
(3) 检查过程中患者应当保持安静,剧烈运动后血中的酸碱度变化可能影响同位素标记CO2的呼出,另外在患者呼气时应当嘱咐患者注意不要将集气瓶中的液体误吸入口腔。
安全性
碳14尿素呼气试验应用于临床十几年,未见到明显的不良反应的报道。专业性评估报告证实碳14呼气试验对患者和操作人员的辐射危险可忽略不计,临床上可以安全使用。
mye-mail:pjlitao@tom.com
mye-mail:pjlitao@tom.com
mye-mail:pjlitao@tom.com
2. 检查流程:
(1) 检查时先让患者口服一粒碳14尿素胶囊。
(2) 静坐25分钟后,受试者直接向集气瓶内呼气,患者呼气后集气瓶中的液体由粉红色变成无色为止,或者患者持续呼气时间已经达到3分钟后即可停止呼气。
(3) 向集气瓶中加入4.5ml稀释闪烁液后,加盖旋紧,置于液闪仪中进行检测。
(4) 检查过程中患者应当保持安静,剧烈运动后血中的酸碱度变化可能影响同位素标记CO2的呼出,另外在患者呼气时应当嘱咐患者注意不要将集气瓶中的液体误吸入口腔。向左转|向右转
有几个问题想问问大家:
1.我看到相当多文献中,结束反应用的是抽滤,由于条件的限制,我们这里没有该装置,所以就取了少数文献中的方法,用12000G离心10min结束反应,然后沉淀TRIS-HCL洗涤3次。测量时在沉淀所在的EP管中加入闪烁液(该闪烁液的配方适用于样品含水量较少的情况),每管1ML。请问大家,这样结束反应行吗?沉淀是否应该烘干?
2.我用的液闪仪计数不是很稳定,如果进行校正,尤其是读数比较小的时候(如只有数百),以减少误差?
3.加入闪烁液后,是否应该避光放置一段时间后再测量?
谢谢!

